QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 0.106
-- x --
-- x --
-- - --
$ 0.03 - $ 0.17
1,474
na
28.75M
$ -461.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-caribou-biosciences-shares-are-trading-higher-by-around-58-here-are-other-stocks-moving-in-thursdays-session

Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equ...

 why-vbi-vaccines-are-trading-lower-by-over-23-here-are-20-stocks-moving-premarket

Gainers Akumin Inc. (NASDAQ: AKU) shares surged 58.2% to $0.2865 in pre-market trading. Akumin recently named Krishna Kumar ...

 nymox-pharmaceutical-says-terminated-employment-of-each-of-cfo-christopher-riley-and-coo-randall-lanham

The Company has initiated a search for a Chief Financial Officer, and is in the process of hiring a general counsel to assume t...

 nymox-provides-current-update
Nymox Provides Current Update
05/10/2023 14:00:55

 Nymox Pharmaceutical Corporation (NASDAQ:NYMX) (the "Company") is pleased to provide a mid-2nd quarter update on ongoi...

 nymox-announces-appointment-of-christopher-r-riley-as-chief-financial-officer

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) (the "Company") is pleased to announce the appointment of Christopher R....

 nymox-officially-granted-extension-until-july-3-2023-to-regain-listing-requirements

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) (the "Company") has officially been granted by NASDAQ an additional peri...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION